ВЫБОР ПРОБИОТИКА ПРИ ИНФЕКЦИОННОЙ ДИАРЕЕ У ДЕТЕЙ: СУЩЕСТВУЕТ ЛИ ПРОБЛЕМА?

Скачать статью в PDF
Номер журнала: 
9
Год издания: 
2015

М. Бехтерева (1,2), кандидат медицинских наук, А. Комарова (1), В. Иванова (1,2), член-корреспондент РАН, профессор 1 -НИИ детских инфекций ФМБА России, Санкт-Петербург 2 -Санкт-Петербургский государственный педиатрический медицинский университет E-mail: mkbechtereva@mail.ru

Основой терапии инфекционной диареи любого типа (в том числе инфекционной) являются адекватная и своевременная регидратация, диетотерапия, энтеросорбция с использованием препаратов с доказанной эффективностью и удобным дозированием.
Ключевые слова: 
кишечные инфекции
дети
инфекционные диареи
лечение
регидратация
диетотерапия
пробиотики
Для цитирования
Бехтерева М., Комарова А., Иванова В. ВЫБОР ПРОБИОТИКА ПРИ ИНФЕКЦИОННОЙ ДИАРЕЕ У ДЕТЕЙ: СУЩЕСТВУЕТ ЛИ ПРОБЛЕМА? . Врач, 2015; (9): 47-51

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

Список литературы: 
  1. Guarino A., Albano F., Ashkenazi S. et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe // J. Pediat. Gastroenterol. Nutr. – 2008; 46 (Suppl. 2): 81–122.
  2. Casburn-Jones A., Farthing M. Management of infectious diarrhoea // Gut. – 2004; 53 (2): 296–305.
  3. Guarino A., Ashkenazi Sh., Gendrel D. et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014 // JPGN. – 2014; 59 (1): 132–52.
  4. Von Sonnenburg F., Tornieporth N., Waiyaki P. et al. Risk and aetiology of diarrhoea at various tourist destinations // Lancet. – 2000; 356: 133–4.
  5. Bartlett J. Clinical practice. Antibiotic-associated diarrhea // N. Engl. J. Med. – 2002; 346: 334–9.
  6. Alam S., Mushtaq M. Antibiotic associated diarrhea in children // Indian J. Pediatr. – 2009; 46 (6): 491–6.
  7. Kim J., Smathers S., Prasad P. et al. Epidemiological Features of Clostridium difficile-Associated Disease Among Inpatients at Children's Hospitals in the United States, 2001–2006 // Pediatrics. – 2008; 122 (6): 1266–70.
  8. Acute diarrhea in adults and children: a global perspective // World Gastroenterology Organisation Global Guidelines. February 2012.
  9. Острые кишечные инфекции у детей. Учебно-методическое пособие. Под ред. В.Ф. Учайкина / М.: ГОУ ВПО РГМУ, 2005; 116 с.
  10. Bellemare S., Hartling L., Wiebe N. et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials // BMC Medicine. – 2004; 2: 11.
  11. Fonseca B., Holdgate A., Craig J. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials // Arch. Pediatr. Adolesc. Med. – 2004; 158 (5): 483–90.
  12. Горелов А.В., Усенко Д.В. Ротавирусная инфекция у детей // Вопр. соврем. педиатрии – 2008; 7 (6): 78–84.
  13. Szajewska H., Guarino A., Hojsak I. et al. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics // J. Pediatr. Gastroenterol. Nutr. – 2014; 58 (4): 531–9.
  14. Hickson M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection // Therap. Adv. Gastroenterol. – 2011; 4 (3): 185–97.
  15. Preidis G., Hill C., Guerrant R. et al. Probiotics, Enteric and Diarrheal Diseases, and Global Health // Gastroenterology. – 2011; 140: 8–14.
  16. Kirjavainen P., Ouwehand A., Isolauri E. et al. The ability of probiotic bacteria to bind to human intestinal mucus // FEMS Microbiology Letters. – 1998; 167: 185–9.
  17. Juntunen M., Kirjavainen P., Ouwehand A. et al. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection // Clin. Diagn. Lab. Immunol. – 2001; 8 (2): 293–6.
  18. Захарова И.Н., Дмитриева Ю.А. Штаммспецифические свойства Bifidobacterium animalis subsp. lactis BB-12 // Эффективная фармакотерапии. – 2013; 4: 8–12.
  19. De Vrese M. The probiotic effects of LA5 and BB-12 – an overview / Chr. Hansen Monograph., 2003.
  20. Romond M. et al. Bifidobacteria and human health: regulatory effect of indigenous bifidobacteria on Escherichia coli intestinal colonization // Anaerobe. – 1997; 3: 131–6.
  21. Cheikhyoussef A. et al. Bifidin I – a new bacteriocin produced by Bifidobacterium infantis BCRC 14602: purification and partial amino acid sequence // Food Control. – 2010; 21: 746–53.
  22. Ishibashi N. et al. Bifidobacteria: their significance in human intestinal health // Mal. J. Nutr. – 1997; 3: 149–59.
  23. Martins F., Silva A., Vieira A. et al. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties // Arch. Microbiol. – 2009; 191: 623–30.
  24. Collado M., Meriluoto J., Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus // Lett. Appl. Microbiol. – 2007; 45: 454–60.
  25. Jacobsen C., Rosenfeldt N., Hayford A. et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans // Appl. Environ Microbiol. – 1999; 65: 4949–56.
  26. Saavedra J., Bauman N., Perman J. et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus // Lancet. – 1994; 344 (8929): 1046–9.
  27. D'Aimmo M., Modesto M., Biavati B. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products // Int. J. Food Microbiol. – 2007; 115 (1): 35–42.
  28. Chatterjee S., Kar P., Das T. et al. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA5 and Bifidobacterium BB12 for prevention of antibiotic-associated diarrhoea // J. Assoc. Physicians India. – 2013; 61 (10): 708–12.
  29. McFarland L. Meta-analysis of probiotics for the prevention of traveler’s diarrhea // Travel Medicine and Infectious Disease. – 2007; 5: 97–105.